Evoke Pharma Inc (EVOK NASDAQ) stock market data APIs
$6.0504
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
Evoke Pharma Inc Financial Data Overview
Price chart is built with
Anychart
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.
Prev. Close
6.0504
Open
6.0504
High
6.4662
Low
5.791
52 wk Range
1.94-9.88
Market Cap
8 972 K
Shares Outstanding
1 493 K
Revenue
11 594 K
EPS
-0.51
Beta
0.025
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evoke Pharma Inc data using free add-ons & libraries
Get Evoke Pharma Inc Fundamental Data
Evoke Pharma Inc Fundamental data includes:
- Net Revenue: 11 594 K
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.33
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evoke Pharma Inc News
New
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.49%
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Technology, Utilities and Industrials sectors led shares higher. At the close in NYSE, the Dow Jones Industrial...
Evoke Pharma stock soars after receiving patent allowance for GIMOTI
Investing.com -- Evoke Pharma Inc (NASDAQ:EVOK) stock surged 50% after the specialty pharmaceutical company received a Notice of Allowance from the United States Patent and Trademark Office for a pate...
Evoke Pharma receives patent allowance for gastroparesis nasal spray
SOLANA BEACH, Calif. - Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company with a market capitalization of $5.38 million and impressive revenue growth of ~90% over the last twelve mon...
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
